NihBiotechGrantPulse / compare
REMEDY PLAN vs ORIGIN ENDOSCOPY INC.: NihBiotechGrantPulse comparison
ORIGIN ENDOSCOPY INC.'s award of $1,212,289 is 1.0x REMEDY PLAN's $1,181,436 (90th percentile). REMEDY PLAN is dated 2026-09-17; ORIGIN ENDOSCOPY INC. 2026-09-14.
Data as of · Compiled by Zalwin from NIH RePORTER (newly awarded projects)
Both records plus every comparable MD record, with all columns and source links · Card, Apple Pay, Google Pay or Link via Stripe
How does REMEDY PLAN compare to ORIGIN ENDOSCOPY INC.?
| Field | REMEDY PLAN | ORIGIN ENDOSCOPY INC. |
|---|---|---|
| Organization | REMEDY PLAN | ORIGIN ENDOSCOPY INC. |
| Location | GAITHERSBURG, MD | BALTIMORE, MD |
| Project | Preclinical validation of NAMPT and PARP inhibitor combinations for breast cancer to support clinical studies | Development of EpiMAX, a first-in-class injectable hemostatic agent for long-acting hemostasis of gastrointestinal bleeding |
| Project number | 1R44CA314487-01 | 1R44DK145328-01A1 |
| Mechanism | R44 | R44 |
| Institute | National Cancer Institute | National Institute of Diabetes and Digestive and Kidney Diseases |
| Award | $1,181,436 | $1,212,289 |
| Awarded | 2026-09-17 | 2026-09-14 |
| Project period | 2026-09-18 to 2028-08-31 | 2026-09-15 to 2028-08-31 |
| UEI | E8FJP3A42GC6 | FNG7WGQLJ2U6 |
| award percentile | 90th | 90th |
| Lab Budget Score | 70/100 | 70/100 |
| Peer rank and all 463 MD records (CSV) | 🔒 Click to unlock → | |
| Official source URLs for every peer record | 🔒 Click to unlock → | |
Official records: REMEDY PLAN · ORIGIN ENDOSCOPY INC.
Get newly funded labs in your territory
NihBiotechGrantPulse emails new awards matching your states, mechanisms and minimum award.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.